Clinical Trials: Macular Edema

Mesa : Barnet Dulaney Perkins Eye Center

Computer Detection of Diabetic Retinopathy Compared to Clinical Examination

Phoenix : Barnet Dulaney Perkins Eye Center

Computer Detection of Diabetic Retinopathy Compared to Clinical Examination

Phoenix : Retina Consultants of Arizona

PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)

Bakersfield : California Retina Consultants

Lucentis for Macular Edema Associated With Central Retinal Vein Occlusion

Beverly Hills : Retina-Vitreous Associates

PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)

Beverly Hills :

Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular Edema

Huntington Beach : South Coast Retina

Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab

Long Beach : South Coast Retina

Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab

View More »

Los Angeles : Jules Stein Eye Institute

Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein Occlusion

Marietta : Marietta Eye Clinic

Continuation of Previous Study to Gather More Data on Effect of Macugen on the Corneal Endothelium

Sacramento : Retinal Consultants Medical Group, Inc.

PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)

Santa Barbara : California Retina Consultants

Lucentis for Macular Edema Associated With Central Retinal Vein Occlusion

Santa Maria : California Retina Consultants

Lucentis for Macular Edema Associated With Central Retinal Vein Occlusion

Santa Monica : Thomas Hanscom AMC

Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab

Torrance : Retina Macula Institute

Efficacy of an Intravitreal DEX Implant in Retinal Vein Occlusion Following Treatment With Anti-VEGF Injections.

Torrance : South Coast Retina

Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab

Torrance : Retina Macula Institute

Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema

Clearwater : Retina Vitreous Associates of Florida

Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema

Fort Lauderdale : Retina Group of Florida

Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO

Lakeland : Central Florida Retina Institute

Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for DME

Miami : Bascom Palmer Eye Insitute

Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema

Palm Beach Gardens : Bascom Palmer of the Palm Beaches

Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema

View More »

St. Petersburg : Retina Vitreous Associates of Florida

Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema

Winter Haven : Center for Retina and Macular Disease

PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)

Winter Haven :

Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular Edema

Indianapolis : Thomas A. Cuilla, MD, PC at Midwest Eye Institute

PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)

Cedar Rapids : Iowa Eye Center

Computer Detection of Diabetic Retinopathy Compared to Clinical Examination

Iowa City : University of Iowa Department of Ophthalmology and Visual Sciences

Computer Detection of Diabetic Retinopathy Compared to Clinical Examination

Marshalltown : Wolfe Eye Clinic

Continuation of Previous Study to Gather More Data on Effect of Macugen on the Corneal Endothelium

Lexington : University of Kentucky Chandler Medical Center

Eye Conditions: Eye Research Study on Macular Edema Due to Retinal Vein Blockage.

View More »

Lexington : University of Kentucky Department of Ophthalmology

Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina

Paducah : Paducah Retinal Center

Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for DME

Baltimore : Wilmer Eye Institute, Johns Hopkins University

A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study)

Baltimore : Elman Retina Group, P.A.

Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for DME

Baltimore : Johns Hopkins Unversity

Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO

Baltimore :

Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular Edema

Baltimore : Johns Hopkins University

SAR 1118 in Human Subjects Undergoing Pars Plana Vitrectomy

View More »

Hagerstown : Cumberland Valley Retina Center

Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein Occlusion

Boston :

Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina

Boston :

Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular Edema

Boston : Ophthalmic Consultants of Boston

Safety Study of Bromfenac Ophthalmic Solution in Subjects With Diffuse Diabetic Macular Edema (DME) Refractory to Laser

Chesterfield : St. Lukes Hospital

Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane

St. Louis : Barnes Jewish Hospital

Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane

St. Louis : St. Louis Eye Surgery and Laser Center

Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane

St. Louis : Washington University School of Medicine

Intravitreal Aflibercept Injection for Radiation Retinopathy

Portsmouth : Eyesight Ophthalmic Services, PA

PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)

Toms River : Retina Vitreous Center

PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)

New York : Retina Specialists PC

Ozurdex for Macular Edema Post Membrane Peeling

Charlotte : Southeast Clinical Research Associates, LLC

PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)

Charlotte :

Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular Edema

Cincinnati :

Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular Edema

Cleveland : Cole Eye Institute

Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina

West Mifflin : Associates in Ophthalmology

Continuation of Previous Study to Gather More Data on Effect of Macugen on the Corneal Endothelium

Columbia : Palmetto Retina Center

Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein Occlusion

Rapid City : Black Hills Regioinal Eye Institute

PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)

Arlington :

Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema

Harlingen : Valley Retina Institute

Continuation of Previous Study to Gather More Data on Effect of Macugen on the Corneal Endothelium

Houston : Retina Consultants of Houston

Computer Detection of Diabetic Retinopathy Compared to Clinical Examination

Houston : Robert Cizik Eye Clinic - University of Texas Houston

Computer Detection of Diabetic Retinopathy Compared to Clinical Examination

Houston : Retina Consultants of Houston

Efficacy and Safety Trial of Intravitreal Injections Combined With PRP for the Treatment of CSME Secondary to Diabetes Mellitus (DAVE)

View More »

Houston : Retinal Consultants of Houston

PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)

McAllen : Valley Retina Institute

Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO

McAllen : Valley Retina Institute

PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)

San Antonio : Retinal Consultants of San Antonio

PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)

Buenos Aires : Novartis Investigative Site

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Rosario : Novartis Investigative site

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Adelaide : Novartis Investigative Site

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Brisbane : Novartis Investigative Site

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

East Melbourne : Novartis Investigative Site

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Fitzroy : Novartis Investigative Site

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Forster : Novartis Investigative Site

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

View More »

Hobart : Novartis Investigative Site

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Kogarah : Novartis Investigative Site

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

North Adelaide : Novartis Investigative Site

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Parramatta : Novartis Investigative Site

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

South Launceston : Novartis Investigative Site

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Strathfield : Novartis Investigative Site

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Sydney : Novartis Investigative Site

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Westmead : Novartis Investigative Site

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Bonheiden : Novartis Investigative site

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Hasselt : Novartis Investigative site

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Leuven : Novartis Investigative Site

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Calgary : Calgary Retina Consultants

Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)

Drummondville : Clinique ChirurgiVision

Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)

Halifax : Victoria General Hospital, Department of Ophthalmology

Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)

London : Ivey Eye Institute

Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)

London Ontario : Novartis Investigative Site

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

View More »

Miramichi : Novartis Investigative Site

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Mississauga : Canadian Centre for Advanced Eye Therapeutics

Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)

Montreal : Hôpital Notre Dame (CHUM)

Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)

Montreal : Hôpital Maisonneuve-Rosemont

Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)

Montreal : Royal Victoria Hospital

Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)

Ottawa : The Ottawa Hospital - General Campus

Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)

Quebec : Institut de l'oeil des Laurentides

Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)

Québec : Centre Oculaire de Québec

Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)

Saskatoon : Saskatoon City Hospital / Spadina Clinic

Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)

Sherbrooke : Dr.Michel Giunta Clinique Médicale

Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)

St-John's : Memorial University Health Sciences Centre / Bense Eye Centre

Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)

St-John's : Memorial University Health Sciences Centre / Newfoundland Drive Medical Clinic

Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)

Toronto : Sunnybrook Health Sciences Centre

Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)

Toronto : Toronto Western Hospital

Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)

Toronto : St-Michael's Hospital - Dept of Ophthalmology

Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)

Vancouver : UBC - Eye Care Center

Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)

Victoria : Novartis Investigative Site

Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion

Victoria : Retina Consultants of Victoria

Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)

Beijing :

Safety and Efficacy Study of Dexamethasone in the Treatment of Patients With Macular Edema Following Retinal Vein Occlusion (RVO)

Copenhagen :

Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO)

Glostrup : GSK Investigational Site

A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema

Paris :

Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema

Paris :

Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion

Ahaus :

Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema

Augsburg : Novartis Investigative Site

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Bad Rothenfelde : Novartis Investigative Site

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Berlin :

A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO)

Berlin : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

View More »

Berlin : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

Berlin : Novartis Investigative Site

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Bonn : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Bonn : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

Bonn : Novartis Investigative Site

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Bremen : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Bremen : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

Chemnitz : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Chemnitz : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

Chemnitz : Novartis Investigative Site

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Darmstadt : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Darmstadt : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

Darmstadt : Novartis Investigative Site

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Dortmund : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Dortmund : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

Dresden : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Dresden : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

Dresden : Novartis Investigative Site

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Duesseldorf : Novartis Investigative Site

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Düsseldorf : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Düsseldorf : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

Düsseldorf : Novartis Investigative Site

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Essen : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Essen : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

Frankfurt : Novartis Investigative Site

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Freiburg : GSK Investigational Site

A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema

Freiburg : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Freiburg : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

Freiburg i. Br : Novartis Investigative Site

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Glauchau : Novartis Investigative Site

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Göttingen : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Göttingen : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

Göttingen : Novartis Investigative Site

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Hagen : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Hagen : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

Halle : Novartis Investigative Site

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Hamburg : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Hamburg : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

Hamburg : Novartis Investigative Site

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Ingolstadt : Novartis Investigative Site

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Karlsruhe : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Karlsruhe : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

Karlsruhe : Novartis Investigative Site

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Kiel : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Kiel : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

Koeln : GSK Investigational Site

A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema

Koeln : Novartis Investigative Site

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Köln : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Köln : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

Leipzig : GSK Investigational Site

A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema

Leipzig : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Leipzig : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

Leipzig : Novartis Investigative Site

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Lüdenscheid : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Lüdenscheid : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

Ludwigshafen : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Ludwigshafen : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

Marburg : Novartis Investigative Site

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Muelheim : Novartis Investigative Site

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Muenster : GSK Investigational Site

A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema

Muenster : Novartis Investigative Site

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Mühlheim : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Mühlheim : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

München : Novartis Investigative Site

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Munich : Novartis Investigative Site

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Munich :

Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion

Münster : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Münster : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

Nürnberg : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Nürnberg : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

Postdam : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Postdam : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

Recklinghausen : Novartis Investigative Site

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Regensburg : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Regensburg : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

Regensburg : Novartis Investigative Site

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Siegburg : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Siegburg : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

Sulzbach : Novartis Investigative Site

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Tübingen : Novartis Investigative Site

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Ulm :

A Long-Term Safety Study of OZURDEX® in Clinical Practice

Ulm : GSK Investigational Site

A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema

Ulm : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Ulm : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

Ulm : Novartis Investigative Site

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Wolfsburg : Novartis Investigative Site

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Würzburg : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Würzburg : Novartis Investigative Site

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

Jerusalem : Hadassah Ein Kerem Medical Center

PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)

Petah Tiqva : Rabin Medical Center

PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)

Rehovot : Kaplan Medical Center

PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)

Tel Aviv : Tel Aviv Sourasky Medical Center

Evaluation of the Effects of Selective Photocoagulation for the Treatment of Diabetic Macular Edema

Tel Aviv : Tel Aviv Sourasky Medical Center

PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)

View More »

Tel Aviv :

Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema

Tel Aviv :

Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion

Zerifin : Assaf Harofe Medical Center

PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)

Milan :

Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion

Milano : GSK Investigational Site

A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema

Osaka : Santen study sites

Efficacy and Safety of Betamethasone Microsphere in Patients With Diabetic Macular Edema (TSUBASA)

Osaka : Santen study sites

Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI)

Seoul : Santen study sites

Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI)

Rotterdam : GSK Investigational Site

A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema

Tilburg : Novartis Investigative Site

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Bodo : Novartis Investigative site

Ranibizumab "Treat and Extend" in Diabetic Macular Edma

Oslo :

Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO)

Oslo : Novartis Investigative Site

Ranibizumab "Treat and Extend" in Diabetic Macular Edma

Trondheim : Novartis Investigative site

Ranibizumab "Treat and Extend" in Diabetic Macular Edma

Bielsko-Biala : Novartis Investigative Site

Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion

Coimbra :

Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema

Singapore : Novartis Investigative Site

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Barcelona :

Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema

Madrid :

Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion

Uppsala :

Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO)

Ayr : Novartis Investigative Site

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment

Birmingham : Novartis Investigative Site

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment

Bolton : Novartis Investigative Site

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Bradford :

A Long-Term Safety Study of OZURDEX® in Clinical Practice

Cardiff : Novartis Investigative Site

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment

View More »

Colchester : Novartis Investigative Site

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment

County Durham : Novartis Investigative Site

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Devon : Novartis Investigative Site

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment

Dunfermline : Novartis Investigative Site

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment

Essex : Novartis Investigative Site

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Hull : Novartis Investigative Site

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment

Liverpool : Novartis Investigational Site

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment

London : Novartis Investigative Site

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment

London :

Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema

London :

Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion

London : Moorfields Eye Hospital NHSFT Research and Treatment Centre

The LIMO Study, Lucentis for Treatment of Uveitic Patients With Refractory Cystoid Macular Oedema

Manchester : Novartis Investigative Site

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Norfolk : Novartis Investigative Site

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Norfolk : Novartis Investigative Site

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment

Rugby : Novartis Investigative Site

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment

Sheffield : Novartis Investigative Site

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Stoke on Trent : Novartis Investigative Site

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Surrey : Novartis Investigative site

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Uxbridge : Novartis Investigative Site

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment

York : Novartis Investigative Site

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment